Fast track for dementia drug good news for Axovant and new CEO June 19, 2017 Axovant has gained FDA fast track designation for its pipeline drug nelotanserin, a treatment for visual hallucinations suffered Share X Fast track for dementia drug good news for Axovant and new CEO https://pharmaphorum.com/news/fast-track-dementia-drug-good-news-axovant-new-ceo/
After attracting star CEO Hung, Axovant looks to raise $125m April 12, 2017 Axovant Sciences is maintaining its momentum following the appointment of star biotech leader David Hung earlier this week Share X After attracting star CEO Hung, Axovant looks to raise $125m https://pharmaphorum.com/news/attracting-star-ceo-hung-axovant-looks-raise-125m/
